Vaccine for chikungunya


United States

The first vaccine for the prevention of disease caused by the chikungunya virus was approved by the US Food and Drug Administration on 9 November – the result of years of research and development by the French company Valneva SE. The vaccine, Ixchiq, was given an accelerated approval on evidence of its ability to arrest the spread of chikungunya virus disease, an emerging global health threat.